Stephen Z Shapiro1, Kenneth A Sabacinski1, Samuel A Mansour1, Nikolas B Echeverry1, Sumedh S Shah2, Alan A Stein3, Brian M Snelling4. 1. Department of Student Affairs, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA. 2. Department of Student Affairs, University of Miami Miller School of Medicine, Miami, Florida, USA. 3. Department of Neurological Surgery, New York Medical College, Valhalla, New York, USA. 4. Department of Student Affairs, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA; Marcus Neuroscience Institute, Boca Raton Regional Hospital, Boca Raton, Florida, USA. Electronic address: brian.m.snelling@gmail.com.
Abstract
BACKGROUND: Traditional manual retraction to access deep-seated brain lesions has been associated with complications related to vascular compromise of cerebral tissue. Various techniques have been developed over time to minimize injury, such as self-sustaining retractors, neuronavigation, and endoscopic approaches. Recently, tubular retractors, such as the ViewSite Brain Access System (VBAS), have been developed to reduce mechanical damage from retraction by dispersing the force of the retractor radially over the parenchyma. Therefore, we sought to review the current literature to accurately assess the indications, benefits, and complications associated with use of VBAS retractors. METHODS: A literature search for English articles published between 2005 and 2019 was performed using the MEDLINE database archive with the search terminology "Vycor OR ViewSite OR Brain-Access-System NOT glass." The VBAS website was also examined. Only articles detailing neurosurgical procedures using the VBAS tubular retractor system alone, or in combination with other retractors, were included. Postoperative morbidity and mortality were analyzed to estimate complications linked to using the retractor. RESULTS: Twelve publications (106 patients) met the inclusion criteria. The VBAS retractor was used for tumor resections, hematoma evacuations, cyst removal, foreign body extractions, and lesion resection in toxoplasmosis and multiple sclerosis. These cases were subdivided into groups based on lesion location, size, and resection volume for further analysis. Gross total resection was achieved in 63% of tumor excisions, and subtotal resection was achieved in 37%. Hematoma evacuation was successful in all cases. There were 3 short-term postoperative complications linked to the retractor, with an overall complication rate of 2.8%. CONCLUSIONS: This report is the first formal assessment of the VBAS, highlighting technical considerations of the retractor from the surgeon's perspective, patient outcomes, and complications. The retractor is a safe and efficacious tubular retraction system that can be used for tumor biopsy and resection, colloid cyst removal, hematoma evacuation, and removal of foreign bodies. However, further randomized controlled trials are indicated to accurately assess complication rates and outcomes.
BACKGROUND: Traditional manual retraction to access deep-seated brain lesions has been associated with complications related to vascular compromise of cerebral tissue. Various techniques have been developed over time to minimize injury, such as self-sustaining retractors, neuronavigation, and endoscopic approaches. Recently, tubular retractors, such as the ViewSite Brain Access System (VBAS), have been developed to reduce mechanical damage from retraction by dispersing the force of the retractor radially over the parenchyma. Therefore, we sought to review the current literature to accurately assess the indications, benefits, and complications associated with use of VBAS retractors. METHODS: A literature search for English articles published between 2005 and 2019 was performed using the MEDLINE database archive with the search terminology "Vycor OR ViewSite OR Brain-Access-System NOT glass." The VBAS website was also examined. Only articles detailing neurosurgical procedures using the VBAS tubular retractor system alone, or in combination with other retractors, were included. Postoperative morbidity and mortality were analyzed to estimate complications linked to using the retractor. RESULTS: Twelve publications (106 patients) met the inclusion criteria. The VBAS retractor was used for tumor resections, hematoma evacuations, cyst removal, foreign body extractions, and lesion resection in toxoplasmosis and multiple sclerosis. These cases were subdivided into groups based on lesion location, size, and resection volume for further analysis. Gross total resection was achieved in 63% of tumor excisions, and subtotal resection was achieved in 37%. Hematoma evacuation was successful in all cases. There were 3 short-term postoperative complications linked to the retractor, with an overall complication rate of 2.8%. CONCLUSIONS: This report is the first formal assessment of the VBAS, highlighting technical considerations of the retractor from the surgeon's perspective, patient outcomes, and complications. The retractor is a safe and efficacious tubular retraction system that can be used for tumor biopsy and resection, colloid cyst removal, hematoma evacuation, and removal of foreign bodies. However, further randomized controlled trials are indicated to accurately assess complication rates and outcomes.
Authors: Sun Jay Yoo; Jody Mou; Reena Elizebath; Ananyaa Sivakumar; Rene DeBrabander; Mark Shifman; Kevin Tu; Wataru Ishida; Mohammed Fouda; Amir Manbachi; Alan Cohen Journal: Proc 2021 Des Med Devices Conf DMD2021 (2021) Date: 2021-05-11
Authors: Tomas Amadeo; Daniel Van Lewen; Taylor Janke; Tommaso Ranzani; Anand Devaiah; Urvashi Upadhyay; Sheila Russo Journal: Front Robot AI Date: 2022-01-14
Authors: J Javier Cuellar-Hernandez; Miguel Angel Lopez-Gonzalez; J Ramon Olivas-Campos; Paulo M Tabera-Tarello; Carlos Seañez-Prieto; Timothy Marc Eastin; Minwoo Song Journal: Surg Neurol Int Date: 2021-09-06